What Woven Orthopedic Technologies does

Woven Orthopedic Technologies, LLC (dba Woven Orthopedics) is a US-based, privately held orthopedic medical device company developing the Ogmend® Implant Enhancement System, a patented, off-the-shelf implantable sleeve designed to secure stable screw fixation in compromised bone. The product targets two primary clinical scenarios: augmentation of pedicle screw fixation in posterior thoracolumbar spine fusion when a screw has lost purchase, and rescue of long-bone fracture fixation constructs when screw purchase has been lost in trauma plating. The device addresses a focused failure mode at the screw-bone interface by distributing focal stresses, facilitating rapid bone ingrowth, and increasing surface area contact to improve immediate and long-term fixation strength.

The company holds FDA 510(k) clearance for its spine indication (March 2023), FDA 510(k) De Novo clearance for the trauma indication, and a second FDA spine clearance (February 2024) for a Large-size variant, alongside CE Mark certification for the spine system. Clinical evidence includes 24-month patient follow-up data published in peer-reviewed journals (European Spine Journal, The Spine Journal, VCOT) and ongoing trials at Hospital for Special Surgery, NY Presbyterian, and Nottingham University Hospitals / Queens Medical Centre. Strategic partners include Viscogliosi Brothers (financial), MCRA (regulatory), and MedTech Innovator (accelerator cohort 2022), with deep commercial and clinical leadership drawn from K2M/Stryker, DePuy Synthes, Medtronic, and HSS.

Woven generates revenue by selling Ogmend® implants directly to US hospitals and surgical centers (online ordering and direct sales contacts) and through a partner portal for distributors, with sales-led motion targeting spine and trauma surgeons via clinical data, training programs, and conference engagement. The company has raised approximately $23.5M in disclosed equity across multiple rounds between 2013 and 2018, with additional non-dilutive recognition through Keiretsu Forum, Silicon Review, Becker's Healthcare, and Orthopedics This Week awards. It is a small organization (11–50 employees) in early US commercial scale-up following its 2023 FDA spine clearance.

Name

Woven Orthopedic Technologies

Legal name

Woven Orthopedic Technologies LLC

Website

https://wovenorthopedics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Woven Orthopedic Technologies is a US-based, privately held medical device company that develops and sells the FDA-cleared, CE-marked Ogmend® Implant Enhancement System, an implantable sleeve that augments pedicle screw fixation in spine surgery and rescues failed long-bone fracture fixation in trauma, serving spine and trauma surgeons at hospitals and surgical centers.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

Keywords

• Orthopedic implant devices
• Spinal fixation systems
• Trauma surgery implants
• Screw enhancement technology
• Medical device manufacturing

Headquarters

HQ city

Manchester

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales - Ogmend® System: Sale of implantable medical devices (Ogmend® sleeves) for orthopedic and spine surgery applications. The company manufactures and sells FDA-cleared and CE-marked implant enhancement systems. Products are sold directly to healthcare facilities and through distribution partners.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Woven Orthopedic Technologies develops, manufactures, and commercializes the Ogmend® Implant Enhancement System, a patented implantable sleeve designed to secure stable screw fixation in challenging orthopedic scenarios. The company sells FDA-cleared and CE-marked implant systems (Ogmend Spine System and Ogmend Trauma System) to hospitals, surgical centers, spine surgeons, and trauma surgeons for use in posterior spinal fusion and long bone fracture fixation procedures, particularly in patients with compromised bone quality.

Product overview

Woven Orthopedic Technologies offers the Ogmend® Implant Enhancement System as its core product portfolio. The system consists of two main configurations: the Ogmend® Spine System and the Ogmend® Trauma System. Both are variations of a simple, off-the-shelf implantable sleeve designed to secure stable screw fixation in challenging orthopedic scenarios. The Spine System is cleared for both FDA and CE Mark use in augmenting pedicle screw fixation, while the Trauma System holds FDA De Novo clearance for long bone fracture fixation applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Ogmend® Implant Enhancement System A patented, off-the-shelf implantable sleeve designed to quickly and easily secure stable screw fixation in challenging orthopedic scenarios, addressing high-risk and complex patients with compromised screw-bone interfaces. It is sold as the company's core product family.
• Ogmend® Spine System FDA-cleared and CE-marked implant enhancement system intended to augment pedicle screw fixation when a screw has lost purchase due to loosening, back-out, or breakage, for use with rigid thoracolumbar pedicle screw systems in skeletally mature patients.
• Ogmend® Trauma System FDA 510(k) De Novo cleared implant enhancement system for use with screws as part of a fracture fixation plate system in long bones in rescue scenarios where screw purchase has been lost and construct stability is at risk, for skeletally mature patients.
• Ogmend® Large Size (Spine) Larger size variant of the Ogmend® Spine System, FDA-cleared to augment pedicle screw fixation in spine surgery for skeletally mature patients requiring the larger configuration.

Quantifiable outcome

• 24-month clinical follow-up data demonstrating effectiveness of Ogmend® treatment in spine surgery patients
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• MCRA, LLCcoreImplementation/ SI/ Consulting PartnerRegulatory advisory company where Anthony Viscogliosi serves as CEO. MCRA is responsible for many of the FDA clearances obtained by orthopedic companies. Provides regulatory guidance for product clearance processes.
• Hospital for Special Surgery (HSS)coreOthersDr. David Helfet serves as Chief Emeritus of the Orthopedic Trauma Service. Clinical trials conducted at HSS and associated institutions including NY Presbyterian Hospital and Nottingham University Hospitals, Queens Medical Centre.
• MedTech InnovatorminorGTM or Marketing PartnerSelected for the prestigious MedTech Innovator showcase and accelerator cohort in 2022, providing visibility and potential partnership opportunities within the medtech ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SI-BONE: SI-BONE is a small-cap specialty orthopedic medtech commercializing the iFuse implant system for sacroiliac joint fusion. Comparable to Woven as a focused, FDA-cleared, surgeon-driven orthopedic implant company targeting a specific under-served fixation niche with similar go-to-market dynamics.
• Spinal Elements: Spinal Elements is a privately held spine hardware company offering fixation systems, interbody devices, and procedural solutions. Directly comparable to Woven as a specialty spine implant company competing for surgeon adoption in pedicle screw and related fixation procedures.
• LifeSpine: LifeSpine is a privately held specialty spine implant company focused on minimally invasive screw and interbody systems. Directly comparable to Woven as a competing screw-system adjacencies player targeting similar spine surgeon customers with overlapping pedicle screw indications.
• Centinel Spine: Centinel Spine is a privately held spine device company with a portfolio including cervical and lumbar fixation solutions. Comparable to Woven as a specialty spine hardware company pursuing incremental innovation in the fixation space and selling to similar spine surgeon customers.
• OrthoPediatrics: OrthoPediatrics is a publicly traded orthopedic implant company focused exclusively on pediatric and small-patient orthopedic surgery. Comparable to Woven as a specialty orthopedic implant company with a focused portfolio, surgeon-driven sales model, and similar commercialization challenges in a niche within broader orthopedic markets.
• Alphatec Spine: Alphatec Spine (now ATEC) is a publicly traded spine-focused medical device company developing fixation and procedural solutions for spine surgeons. Comparable to Woven as a spine hardware company with overlapping pedicle screw product lines and the same surgeon customer base.

Broad incumbents

• Stryker: Stryker is one of the largest global orthopedic and spine device companies, having acquired K2M Group (founded by Woven's Chairman Andrew Rock) for $1.4B. Stryker sells pedicle screw systems and other fixation products to the same spine and trauma surgeons Woven targets, and is the most likely strategic acquirer of an augmentation adjunct like Ogmend.
• Medtronic: Medtronic is the largest spine hardware company globally, selling CD Horizon and other pedicle screw systems used in the same procedures where Ogmend is positioned. Multiple Woven senior leaders (CLO Terrance Carlson, Clinical Specialist Karen McRae) came from Medtronic. Comparable as the dominant incumbent against whom Woven's screw-augmentation adjunct is differentiated.
• DePuy Synthes (Johnson & Johnson MedTech): DePuy Synthes, the orthopedics arm of Johnson & Johnson, is a leading spine and trauma fixation company selling EXPEDIUM and other pedicle screw systems. Comparable as a broad incumbent in spine and trauma where Ogmend's sleeve is used; J&J's prior Synthes acquisition at $20B (where Woven CLO worked) is a reference data point for orthopedic exit values.

Emerging players

• Anika Therapeutics: Anika Therapeutics is a publicly traded mid-cap orthopedic company focused on joint preservation, regenerative therapies, and surgical solutions. Comparable to Woven as a small-cap publicly traded orthopedic device company pursuing adjacent fixation-related indications with similar regulatory pathway dynamics.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/woven-orthopedic-technologies-llc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds7 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Woven Orthopedic Technologies